Jesper Damsgaard Gunst

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

Jesper Damsgaard Gunst, Marie H. Pahus, Lena Hagelskjær Kristensen et al. · EClinicalMedicine · 2021 · 197 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +3

SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

Line K. Vibholm, Stine Sofie Frank Nielsen, Marie H. Pahus et al. · EBioMedicine · 2021 · 168 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Jesper Damsgaard Gunst, Marie H. Pahus, Míriam Rosás-Umbert et al. · Nature Medicine · 2022 · 140 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection

Renée M. van der Sluis, Lamin B. Cham, Albert Gris‐Oliver et al. · The EMBO Journal · 2022 · 101 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Míriam Rosás-Umbert, Jesper Damsgaard Gunst, Marie H. Pahus et al. · Nature Communications · 2022 · 97 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17